Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision label, Revision: v3.5.4, was added, replacing Revision: v3.5.3. This reflects a minor update to the page's revision history without altering the study information presented.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s displayed system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a platform update rather than a change to the underlying study information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe site version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check76 days agoChange DetectedParaganglioma was added to the study conditions and a Genetic and Rare Diseases Information Center resource was included. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check83 days agoChange Detected- Revision label updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2 to the page. Deleted the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.